Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Publisher
Clinical Chemistry and Laboratory Medicine(1)
Current Pharmacogenomics and Personalized Medicine(1)
Medicina Clinica(1)
OMICS A Journal of Integrative Biology(1)
Pharmacogenomics Journal(1)
Área temáticas
Bioquímica(4)
Enfermedades(3)
Farmacología y terapéutica(3)
Mammalia(1)
Medicina y salud(1)
Origen
scopus(5)
Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: Application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship
ArticleAbstract: The drug-metabolizing cytochrome P450 (CYP) enzyme CYP2D6 is involved in the metabolism of several cPalabras claves:CYP2D6, debrisoquine, HPLC, Metabolic ratioAutores:Adrián LLerena, Berecz R., Cáceres M.C., Cobaleda J., Dorado P., González I.Fuentes:scopusEating disorder symptoms and CYP2D6 variation in cuban healthy females: A report from the Ibero-American network of pharmacogenetics
ArticleAbstract: CYP2D6 is involved in the metabolism of antidepressants drugs and of the endogenous neurotransmitterPalabras claves:Cuban population, CYP2D6, Eating disorder symptoms, Global pharmacogenetics, Healthy females, Public health pharmacogenetics, Ultrarapid metabolizersAutores:Adrián LLerena, Alvárez M., Calzadilla L.R., Dorado P., González I., Naranjo M.E.G., Penãs-Lledó E.M., Pérez B.Fuentes:scopusInterethnic differences in the relevance of CYP2C9 genotype and environmental factors for diclofenac metabolism in Hispanics from Cuba and Spain
ArticleAbstract: The aims of this study were to evaluate the diclofenac metabolism in Hispanics from Cuba and Spain aPalabras claves:CYP2C9, Diclofenac, Environmental factors, Genotype, Hispanics, PhenotypeAutores:Adrián LLerena, Alvárez M., Calzadilla L.R., Cobaleda J., Dorado P., González I., Penãs-Lledó E.M., Pérez B.Fuentes:scopusLessons from Cuba for global precision medicine: CYP2D6 genotype is not a robust pbkp_redictor of CYP2D6 ultrarapid metabolism
ArticleAbstract: A long-standing question and dilemma in precision medicine is whether and to what extent genotypingPalabras claves:Biomarkers, developing world omics, Diagnostic Medicine, Innovation Systems, personalized medicine, system diagnosticsAutores:Adrián LLerena, Calzadilla L.R., de Andrés F., Dorado P., González I., Naranjo M.E.G., Penãs-Lledó E.M.Fuentes:scopusStudy of debrisoquine hydroxylation polymorphism (CYP2D6) in the Cuban population compared to Spaniards
ArticleAbstract: BACKGROUND AND OBJECTIVE: CYP2D6 metabolic capacity shows genetic polymorphism. Two metabolic phenotPalabras claves:Cubans, CYP2D6, debrisoquine, Hispanics, Interethnic variability, pharmacogenetics, Phenotype, SpaniardsAutores:Adrián LLerena, Alvárez M., Dorado P., González I., Pérez B.Fuentes:scopus